| |
hMG
|
HP-hMG
|
r-hFSH
|
Relative difference, %
|
|---|
| | | | |
hMG vs r-hFSH
|
HP-hMG vs r-hFSH
|
|---|
|
Dose per clinical pregnancy, IU*
|
7563
|
7258
|
6536
|
15.7
|
11
|
|
≤35 years
|
7202
|
6695
|
5942
|
21.2
|
12.7
|
|
>35 years
|
8456
|
8100
|
8020
|
5.4
|
1
|
|
Dose per live birth, IU*
|
10,170
|
8390
|
7000
|
45.3
|
19.8
|
|
≤35 years
|
9690
|
7739
|
6364
|
52.2
|
21.6
|
|
>35 years
|
11,371
|
9364
|
8589
|
32.4
|
9
|
- Mean gonadotropin doses required to achieve one clinical pregnancy or one live birth are presented, with relative differences for hMG and HP-hMG compared with r-hFSH.
- *Calculated as the mean dose per cycle/clinical pregnancy rate or live birth rate.
- hMG, human menopausal gonadotropin; HP-hMG, highly purified hMG; ICSI, intracytoplasmic sperm injection; r-hFSH, recombinant human follicle-stimulating hormone.
